Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.6874M
March 31, 2026 -0.6367M
December 31, 2025
September 30, 2025
June 30, 2025
March 31, 2025
December 31, 2024 -1.056M
September 30, 2024 -0.9749M
June 30, 2024 -1.16M
March 31, 2024 -1.245M
December 31, 2023 -0.8608M
September 30, 2023 -1.028M
June 30, 2023 -1.074M
March 31, 2023 -1.187M
December 31, 2022 12.49M
September 30, 2022 12.50M
June 30, 2022 12.78M
March 31, 2022 12.99M
December 31, 2021 -0.8886M
Date Value
September 30, 2021 -0.7046M
June 30, 2021 -0.4845M
March 31, 2021 -0.6626M
December 31, 2020 -0.9491M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
June 30, 2019 -0.1777M
March 31, 2019 -0.1087M
December 31, 2018 -0.5896M
September 30, 2018 -0.7853M
June 30, 2018 -0.7001M
March 31, 2018 -0.7751M
December 31, 2017 -0.2039M
September 30, 2017 -0.0727M
June 30, 2017 -0.0568M
March 31, 2017 -0.0625M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Vyome Holdings, Inc. 0.5245M
Abbott Laboratories 7.824B
AngioDynamics, Inc. -3.873M
Alphatec Holdings, Inc. -5.739M
AtriCure, Inc. 53.11M